title: Pleural-pericardic effusion as uncommon complication in CML patients treated with Imatinib.
authors.forename: Massimo
authors.initials: M
authors.lastname: Breccia
authors.forename: Gianna Maria
authors.initials: GM
authors.lastname: D'Elia
authors.forename: Mariella
authors.initials: M
authors.lastname: D'Andrea
authors.forename: Roberto
authors.initials: R
authors.lastname: Latagliata
authors.forename: Giuliana
authors.initials: G
authors.lastname: Alimena
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001549:Benzamides; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010490:Pericardial Effusion / Q000139:chemically induced* / Q000209:etiology; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects*; D010996:Pleural Effusion / Q000139:chemically induced* / Q000209:etiology; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate